Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients

Cancer

Volumn 73, Issue 1, 1994, Pages 42-47

  Hsu, Hey‐Chi ^a   Peng, Shian‐Yang ^a   Lai, Po‐Lin ^a   Sheu, Jin‐Chuan ^a   Chen, Ding‐Shinn ^b   Lin, Liang‐In ^c   Slagle, Betty L ^c   Butel, Janet S ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

allelotype; hepatocellular carcinoma; loss of heterozygosity; p53

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DIABETES MELLITUS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY;

ADULT; AGED; ALLELES; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHROMOSOME MAPPING; DIABETES MELLITUS; FEMALE; GENE DELETION; GENES, P53; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HETEROZYGOTE; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM (GENETICS); SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0028137784     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940101)73:1<42::AID-CNCR2820730109>3.0.CO;2-D     Document Type: Article

References (27)

1. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma
2. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinoma
3. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma
4. p53: a frequent target for genetic abnormalities in lung cancer
5. p53 allele losses, mutations and expression in breast cancer and their relationship to clinicopathological parameters
6. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
7. A genetic model for colorectal tumorigenesis
8. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RBI gene
9. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the regions of the chromosome commonly deleted in virus‐positive hepatocellular carcinomas
10. Allelotype study of primary hepatocellular carcinoma
11. p53 mutations clusters at codon 249 in hepatitis B virus‐positive hepatocellular carcinomas from China
12. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
13. Banll and Scal RFLPs at the human p53 gene locus
14. Prognostic histologic parameters in resected small hepatocellular carcinoma: a comparison with resected large hepatocellular carcinoma (HCC)
15. Tumor invasiveness and prognosis in resected hepatocellular carcinoma: clinical and pathogenetic implications
16. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules
17. Expression and hypomethylation of alpha‐fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas
18. DNA analysis in the diagnosis of hemoglobin disorders
19. Detection of specific sequences among DNA fragments separated by gel electrophoresis
20. Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate
21. Diabetes mellitus and primary hepatocellular carcinoma
22. Nonviral risk factors for hepatocellular carcinoma in a low‐risk population, the non‐Asians of Los Angeles County, California
23. Alterations of glucose metabolism in chronic liver disease
24. Role of glucose transporters in the cellular insulin resistance of Type II non‐insulin dependent diabetes
25. Polymorphic human insulin‐responsive glucose‐transporter gene on chromosome 17p13
26. Clonal origin of recurrent hepatocellular carcinomas
27. Different pattern of chromosome allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin